By Dr. Chinta Sidharthan Reviewed by Susha Cheriyedath, M.Sc. Apr 9 2025 A groundbreaking preclinical study reveals how targeting a viral enzyme with a new drug could prevent long-COVID complications, offering hope for millions and a powerful tool for future coronavirus threats. Study:  A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID Over 77 million people globally have experienced lingering symptoms after recovering from coronavirus disease 2019 (COVID-19), yet

Tag-uri: Coronavirus